Equities
Health CareMedical Equipment and Services
  • Price (USD)133.11
  • Today's Change2.05 / 1.56%
  • Shares traded888.00k
  • 1 Year change-4.09%
  • Beta0.8971
Data delayed at least 15 minutes, as of Mar 28 2024 20:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It provides diagnostic information services for infectious diseases, such as tuberculosis (e.g., T.SPOT.TB and Quantiferon offerings) and tick-borne disease (e.g., Accutix offering). Its comprehensive offerings in drug monitoring and toxicology, in neurology diagnostics, in advanced cardiovascular diagnostic information services (e.g. CARDIO IQ and Cleveland HeartLab offerings through its Cardiometabolic Center of Excellence), and in cancer diagnostics. Its Diagnostic Solutions business consists of its risk assessment services and healthcare information technology businesses. Its risk assessment service, ExamOne, is a provider of risk assessment services for the life insurance industry in North America.

  • Revenue in USD (TTM)9.25bn
  • Net income in USD850.00m
  • Incorporated1996
  • Employees40.00k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
DGX:NYQ since
announced
Transaction
value
Lenco Diagnostic Laboratories IncDeal completed01 Feb 202401 Feb 2024Deal completed3.64%111.00m
Steward Health Care System LLC-Outreach Laboratory Services Business Select AssetsDeal completed08 Jan 202408 Jan 2024Deal completed-6.25%--
Haystack Oncology IncDeal completed27 Apr 202327 Apr 2023Deal completed-9.35%450.00m
Data delayed at least 15 minutes, as of Mar 28 2024 20:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Encompass Health Corp4.80bn361.60m7.78bn22.36k23.145.0311.041.723.573.4547.3816.430.818--8.36214,761.108.096.3710.217.9495.4595.589.899.16--5.290.541530.7810.412.3441.314.4916.60-10.42
Chemed Corp2.26bn272.51m9.74bn15.09k35.828.7129.114.2917.9217.92148.9973.691.46131.5914.11150,090.6017.5219.5321.7924.6435.2834.6012.0312.601.57--0.0148.156.064.909.175.801.466.10
Tenet Healthcare Corp20.55bn611.00m10.49bn78.14k18.026.534.820.51155.835.83196.0016.090.74098.806.58262,950.404.733.616.755.0982.5382.976.384.951.424.150.73150.007.172.3349.0241.424.01--
Davita Inc12.14bn691.54m12.00bn70.00k18.6311.617.110.99737.417.41130.2911.890.717965.975.89173,430.705.665.627.557.4531.4730.707.888.331.134.770.7536--4.571.2626.442.33-10.47--
Universal Health Services, Inc.14.28bn717.49m12.22bn73.35k17.801.999.530.858810.2510.25203.6691.531.04--6.71194,710.005.246.446.147.63----5.046.551.295.690.4426.066.595.806.32-1.471.1714.87
Quest Diagnostics Inc9.25bn850.00m14.51bn40.00k17.782.3411.161.597.497.4981.5256.820.688932.397.69231,300.006.579.287.5810.8133.1436.649.5312.971.208.470.423425.07-6.384.20-9.773.401.277.43
Laboratory Corporation of Amerc Holdings12.16bn379.20m18.21bn67.00k51.862.3319.181.514.214.65139.1193.860.659518.614.75181,516.402.066.272.497.3727.6732.333.139.511.025.890.3944--2.511.42-62.16-16.403.62--
Data as of Mar 28 2024. Currency figures normalised to Quest Diagnostics Inc's reporting currency: US Dollar USD

Institutional shareholders

40.30%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 202313.10m11.83%
BlackRock Fund Advisorsas of 31 Dec 20236.83m6.17%
SSgA Funds Management, Inc.as of 31 Dec 20235.33m4.82%
American Century Investment Management, Inc.as of 31 Dec 20233.62m3.27%
Victory Capital Management, Inc. (Investment Management)as of 31 Dec 20233.48m3.14%
Davis Selected Advisers LPas of 31 Dec 20232.67m2.41%
Wellington Management Co. LLPas of 31 Dec 20232.63m2.38%
Geode Capital Management LLCas of 31 Dec 20232.53m2.29%
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Dec 20232.45m2.22%
Dimensional Fund Advisors LPas of 31 Dec 20231.97m1.78%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.